Managing Complications in Cirrhotic Patients

Overview

Journal United European Gastroenterol J

Publisher Wiley

Specialty Gastroenterology

Date 2015 Feb 6

PMID 25653862

Citations 3

Authors

Markus Peck-Radosavljevic

Paolo Angeli

Juan Cordoba

Oliver Farges

Dominique Valla

Affiliations

Soon will be listed here.

Abstract

Liver cirrhosis is a serious and potentially life-threatening condition. This life-threatening condition usually arises from complications of cirrhosis. While variceal bleeding is the most acute and probably best studied, several other complications of liver cirrhosis are more insidious in their onset but nevertheless more important for the long-term management and outcome of these patients. This review summarizes the topics discussed during the UEG-EASL Hepatology postgraduate course of the United European Gastroenterology Week 2013 and discusses emergency surgical conditions in cirrhotic patients, the management of hepatic encephalopathy, ascites and hepatorenal syndrome, coagulation disorders, and liver cancer.

Citing Articles

Bariatric Surgery in Cirrhotic Patients: Is It Safe?.

Younus H, Sharma A, Miquel R, Quaglia A, Kanchustambam S, Carswell K Obes Surg. 2019; 30(4):1241-1248.

PMID: 31853866 DOI: 10.1007/s11695-019-04214-7.

Metabolic acidosis in critically ill patients with cirrhosis: Epidemiology and short-term mortality risk factors.

Gao F, Lin M, Yang X, Cai M, Nan H, Xie W Turk J Gastroenterol. 2019; 30(10):883-891.

PMID: 31633484 PMC: 6812953. DOI: 10.5152/tjg.2019.18813.

Diastolic dysfunction in cirrhosis.

Moller S, Wiese S, Halgreen H, Hove J Heart Fail Rev. 2016; 21(5):599-610.

PMID: 27075496 DOI: 10.1007/s10741-016-9552-9.

References

Cordoba J, Ventura-Cots M, Simon-Talero M, Amoros A, Pavesi M, Vilstrup H . Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol. 2013; 60(2):275-81. DOI: 10.1016/j.jhep.2013.10.004. View

Deltenre P, Mathurin P, Dharancy S, Moreau R, Bulois P, Henrion J . Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis. Liver Int. 2005; 25(2):349-56. DOI: 10.1111/j.1478-3231.2005.01095.x. View

DAmico G, Luca A, Morabito A, Miraglia R, DAmico M . Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology. 2005; 129(4):1282-93. DOI: 10.1053/j.gastro.2005.07.031. View

Strauss E, da Costa M . The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis. Hepatogastroenterology. 1998; 45(21):900-4. View

Wong F, Massie D, Hsu P, Dudley F . Indomethacin-induced renal dysfunction in patients with well-compensated cirrhosis. Gastroenterology. 1993; 104(3):869-76. DOI: 10.1016/0016-5085(93)91024-c. View

Kalambokis G, Economou M, Fotopoulos A, Bokharhii J, Pappas C, Katsaraki A . The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites. Am J Gastroenterol. 2005; 100(4):879-85. DOI: 10.1111/j.1572-0241.2005.40899.x. View

Forbes A, Murray-Lyon I . Vancomycin in resistant hepatic encephalopathy. Gut. 1990; 31(12):1424. PMC: 1378785. DOI: 10.1136/gut.31.12.1424-b. View

Mas A, Rodes J, Sunyer L, Rodrigo L, Planas R, Vargas V . Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial. J Hepatol. 2002; 38(1):51-8. DOI: 10.1016/s0168-8278(02)00350-1. View

Forner A, Llovet J, Bruix J . Hepatocellular carcinoma. Lancet. 2012; 379(9822):1245-55. DOI: 10.1016/S0140-6736(11)61347-0. View

10.

Hucke F, Sieghart W, Schoniger-Hekele M, Peck-Radosavljevic M, Muller C . Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program?. Wien Klin Wochenschr. 2011; 123(17-18):542-51. DOI: 10.1007/s00508-011-0033-9. View

11.

Carbonell A, Wolfe L, DeMaria E . Poor outcomes in cirrhosis-associated hernia repair: a nationwide cohort study of 32,033 patients. Hernia. 2005; 9(4):353-7. DOI: 10.1007/s10029-005-0022-x. View

12.

Bellest L, Eschwege V, Poupon R, Chazouilleres O, Robert A . A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology. Hepatology. 2007; 46(2):528-34. DOI: 10.1002/hep.21680. View

13.

Augustin S, Gonzalez A, Genesca J . Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol. 2010; 2(7):261-74. PMC: 2998973. DOI: 10.4254/wjh.v2.i7.261. View

14.

Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A . Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2009; 33(1):41-52. PMC: 2816794. DOI: 10.1007/s00270-009-9711-7. View

15.

Bernardi M, Caraceni P, Navickis R, Wilkes M . Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology. 2011; 55(4):1172-81. DOI: 10.1002/hep.24786. View

16.

Albillos A, Banares R, Gonzalez M, Catalina M, Molinero L . A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol. 2005; 43(6):990-6. DOI: 10.1016/j.jhep.2005.06.005. View

17.

Krok K, Cardenas A . Hepatic hydrothorax. Semin Respir Crit Care Med. 2012; 33(1):3-10. DOI: 10.1055/s-0032-1301729. View

18.

Aoki T, Kokudo N, Matsuyama Y, Izumi N, Ichida T, Kudo M . Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide survey. Ann Surg. 2013; 259(3):532-42. DOI: 10.1097/SLA.0b013e31828846de. View

19.

Garcia-Tsao G, Sanyal A, Grace N, Carey W . Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007; 46(3):922-38. DOI: 10.1002/hep.21907. View

20.

Tripodi A, Mannucci P . The coagulopathy of chronic liver disease. N Engl J Med. 2011; 365(2):147-56. DOI: 10.1056/NEJMra1011170. View